New Immunotherapy Targets Drug-Resistant Cancers

Scientists from Israel's Weizmann Institute have developed a novel approach to combat cancers that resist treatment. Their computational tool, SpotNeoMet, identifies shared neo-antigens from resistance-causing mutations, paving the way for broad-spectrum immunotherapies.

Read the full story on Quick Digest